Petra D. H.
- Country
- Belgium
- Department
- Dermatology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Oral Enpatoran in Adults With Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- Long-Term Safety and Efficacy Evaluation of Litifilimab (BIIB059) in Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus
- Efficacy and Safety Evaluation of Litifilimab in Active Subacute and Chronic Cutaneous Lupus Erythematosus Refractory to Antimalarial Therapy
Data & Insights
Has run more than one trial at 58 of 123 partner sites.
Specializations
Rare Disease Research
The investigator specializes in studying Erythropoietic Protoporphyria (EPP), a rare genetic condition affecting light sensitivity and skin protection mechanisms.
- Photosensitivity disorders
- Genetic skin conditions
- Metabolic disorders
Their research extends to understanding the underlying mechanisms of EPP and its impact on patients' quality of life.
Therapeutic Development
The investigator focuses on advancing treatments for rare photodermatological conditions, with particular emphasis on afamelanotide therapy and its applications.
- Novel therapeutic approaches
- Drug development
- Treatment optimization
Their work encompasses evaluating therapeutic responses across different age groups and patient populations.
Clinical Pharmacology
The investigator studies pharmacokinetics in special patient populations, particularly focusing on age-related differences in drug metabolism and effectiveness.
- Drug metabolism studies
- Age-specific responses
- Therapeutic monitoring
Their research includes comparative analyses between adolescent and adult patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.